Stock BINV BIOINVENT INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications BioInvent International AB

Equities

BINV

SE0015244520

Delayed Nasdaq Stockholm
Other stock markets
 10:15:31 2024-04-23 am EDT 		5-day change 1st Jan Change
23.3 SEK 0.00% Intraday chart for BioInvent International AB +11.22% +22.89%
Apr. 03 BioInvent, Merck & Co. Unit Sign Clinical Trial, Supply Deal for Tumor Treatment as Add-On Therapy for Keytruda MT
Feb. 22 Transcript : BioInvent International AB, 2023 Earnings Call, Feb 22, 2024

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. BINV Stock
  4. News BioInvent International AB
  5. Official Publications